Pharmaceuticals & Biotech

Royalty Income — Out-Licensed Product

Recording royalty income received from a licensee selling a product that uses the company's intellectual property.

Account NameTypeDebit ($)Credit ($)
Royalty ReceivableAsset (+)3,500,000.00-
Royalty / License RevenueRevenue (+)-3,500,000.00

💡 Accountant's Note

Royalties from out-licensed pharmaceutical IP are recognized as the licensee's sales occur, based on the royalty rate applied to net product sales. The licensor receives a royalty report from the licensee quarterly and recognizes revenue when the underlying sales are made (usage-based royalties under IFRS 15).

Practitioner & Systems Framework

💻 ERP Architecture

Royalty income is recognized based on the licensee's quarterly sales reports. Under IFRS 15, usage-based royalties on IP licenses are recognized only when the underlying sales occur — the 'sales-based royalty exception' prevents recognition before the customer's sales. The royalty receivable is posted when the quarterly report is received (the right to receive the royalty is confirmed). If the licensee's quarterly report is received after period-end, an accrual is made based on estimated sales in the quarter. The licensing management system tracks all out-licensed products, royalty rates, and payment timelines.

⚠️ Audit Flags

Auditors obtain the licensee's royalty report and trace the royalty calculation to the underlying net sales data. For material royalty income streams, auditors may request direct confirmation from the licensee of the quarterly royalty amount. Test the accrual methodology for quarters where the licensee's report is received after period-end — the estimate should be based on available sales data (IMS/IQVIA prescription data). Assess whether the royalty rate applied matches the licensing agreement, including any tiered rates at different sales thresholds. Review any royalty audits conducted on the licensee.

📄 Required Documentation

Licensing agreement (royalty rate, payment terms, royalty report obligation), licensee quarterly royalty report, royalty accrual calculation for late reports, IQVIA/IMS prescription data used for estimates, royalty audit rights and any audits conducted, AP/AR reconciliation with the licensee, and geographic royalty breakdown.

Professional Excel Template

Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.

Notify Me on Release
QA

Expert Analysis by Qusai Ahmad

General Accountant Supervisor & IFRS Specialist

Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.

LinkedIn Profile

Discussion & Community Questions